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Background: The influence of multiple gestation on the occurrence of retinopathy of prematurity 
(ROP) is still not completely understood.
Objectives: To verify the incidence of any stage of ROP and threshold ROP in singletons and 
in multiple gestation among preterm infants.
Methods: This was an institutional, prospective, and descriptive cohort study, which included 
preterm newborns with birth weight (BW) of 1500 g or less and/or gestational age (GA) of 
32 weeks or less, as admitted to the neonatal units at Laranjeiras and Amparo Hospitals in Rio 
de Janeiro, Brazil, between January 2001 and July 2005, and whom remained hospitalized 
for at least 28 days. There were no exclusion criteria. Patients were divided into two groups: 
Group 1 included multiples; and Group 2 consisted of singletons.
Results: A total of 159 infants that remained in neonatal unit care for at least 28 days were 
included in this study. Group 1 comprised 56 (35%) multiples; and Group 2 comprised 103 (65%) 
singletons. Mean BW was 1072 g ± 272 and 1089 g ± 282 in Groups 1 and 2, respectively 
(analysis of variance [ANOVA] P . 0.05). Mean GA among multiple gestation (Group 1) was 
29 weeks ± 2.1; and 29 weeks ± 2.4 among singletons (Group 2) (ANOVA P . 0.05). Days in 
oxygen therapy ranged from 0 to 188 days. Median among Group 1 was 15 days, while median 
in Group 2 was 10 days (Kruskal–Wallis P . 0.05). Any stage ROP was detected in 66 (41.5%) 
of the whole cohort comprising 159 babies. Among the 56 multiples, 30 (53.6%) achieved any 
stage ROP, and among 103 singletons, 36 (35%) achieved any stage ROP (Chi-square test 
P , 0.05). Threshold ROP occurred in 12 (7.5%) of the 159 patients included. Three (5.3%) 
patients from Group 1 and nine (8.7%) patients in Group 2 reached threshold ROP needing 
laser treatment (Fisher’s exact test P . 0.05).
Conclusion: This study showed higher frequency of any stage of ROP in twins and triplets but not 
regarding threshold disease. Because of the relatively small number of patients in this sample, 
other studies are necessary to determine if gemelarity plays a role in the occurrence of ROP.
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Introduction
Retinopathy of prematurity (ROP) is a multifactorial disease caused by numerous and 
complex vascular disturbances that occur at the immature retina of preterm neonates.1 
ROP affects peripheral retinal vessels under formation; therefore, it does not occur after 
complete vascularization of the peripheral retina.2,3 Etiology of ROP is not completely 
understood, but several factors related to prematurity seems to be connected to the 
disease.4 Low birth weight (BW), low gestational age (GA), and use of oxygen therapy 
in mechanical ventilation are considered the main risk factors for ROP.5,6
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Children born from multiple pregnancies present a 
higher risk of preterm delivery (GA , 37 weeks after con-
ception). Around 53% of twins and 92% of triplets present 
low BW. Prematurity occurs in 47% of twins and in 91.6% 
of triplets.7
Although twins and triplets do not seem to have a higher 
risk of neonatal disturbances when compared to newborns with 
similar GA and BW from single gestations, there are some 
reports showing a higher incidence of ROP in infants from 
multiple pregnancies.6 The influence of multiple pregnancies 
regarding ROP occurrence is still not completely clear.8–11
The objective of this study is to verify the incidence of 
any stage of ROP and threshold ROP in singletons and in 
multiple-pregnancy newborns, as studied in two different 
neonatal intensive care units (NICUs) in Rio de Janeiro, 
Brazil.
Methods
Study design and population
This was an institutional, prospective, and descriptive cohort 
study, which included preterm newborns with BW of 1500 g 
or less and/or GA of 32 weeks or less at birth admitted to the 
neonatal units at Laranjeiras and Amparo Hospitals in Rio 
de Janeiro, Brazil, between January 2001 and July 2005, and 
whom remained hospitalized for at least 28 days. There were 
no exclusion criteria. Patients were divided into two groups: 
Group 1 included babies born form multiple gestation; and 
Group 2 consisted of singletons. Multiples were defined as 
children born from pregnancies with two or more fetuses 
simultaneously.12
Ophthalmologic examination
All patients were evaluated by two of the authors (Motta, 
Fiorot), both professionals with training for performing ROP 
screening and ROP treatment. Examination consisted of bin-
ocular indirect ophthalmoscopy after pupillary dilation with 
phenylephrine 2.5% and tropicamide 1%. Eye drops were 
administered with 5-minute intervals, starting 40–60 minutes 
before examinations. Ophthalmologic examinations started 
between the fourth and sixth weeks of life, and assessments 
were repeated weekly if any stage of ROP was detected, 
or every 2 weeks until discharge if no ROP had occurred, 
as according to the Brazilian guidelines on the detection 
and treatment of ROP.13 Patients with threshold ROP were 
treated with transpupillary diode laser photocoagulation or 
by cryotherapy ablation.2,14,15
Primary clinical outcomes were ROP onset at any evo-
lutionary stage and onset of severe ROP requiring treatment 
in Groups 1 and 2. Stages of ROP were recorded according 
to the 1984/1987 International Classification,16 and corre-
sponded to the most severe degree of ROP found in either 
eye during the examination period. Threshold disease was 
defined according to cryotherapy for retinopathy of prema-
turity (Cryo-ROP) study.14 ROP incidence was calculated 
for both groups.
Variables used to analyze risk factors for ROP were BW; 
GA (assessed by clinical history, early obstetric ecography, or 
neonatologist evaluation with Ballard or Capurro methods); 
gender; type of pregnancy (single or multiple); and duration 
of oxygen therapy.
Statistical analysis
To analyze the results on the continuous variables with 
normal variances, analysis of variance (ANOVA) tests were 
used, and for those variables with asymmetrical distribution, 
the Kruskal–Wallis test was employed. To analyze the cate-
gorical variables, the Chi-square and Fisher’s exact tests were 
used. Results were considered significant for P , 0.05.
Results
A total of 159 infants remained hospitalized for at least 
28 days and were included in this study. Group 1 comprised 
56 (35%) born from multiple pregnancies; and Group 2 
comprised 103 (65%) singletons. Birth weight ranged 
between 500–1500 g including all patients. Mean BW was 
1072 g ± 272 and 1089 g ± 282 in Groups 1 and 2, respec-
tively (ANOVA P . 0.05).
Gestational age ranged between 24–35 weeks at birth 
including all patients. Mean GA among multiple gestation 
(Group 1) was 29 weeks ± 2.1; and 29 weeks ± 2.4 among 
singletons (ANOVA P . 0.05).
Days in oxygen therapy ranged from 0 to 188 days. 
Median among Group 1 was 15 days while median in 
Group 2 was 10 days (Kruskal–Wallis P . 0.05).
Any stage of ROP was detected in 66 (41.5%) of the 
whole cohort comprising 159 babies. Among the 56 multiple-
pregnancy patients, 30 (53.6%) achieved any stage of ROP; 
and among 103 singleton babies, 36 (35%) of them achieved 
any stage of ROP (Chi-square test P , 0.05, Figure 1).
Threshold ROP occurred in 12 patients (7.5%) of the 
159 patients included. Three patients (5.3%) from Group 1 
and nine patients (8.7%) in Group 2 reached threshold ROP 
needing diode laser treatment (Fisher’s exact test P . 0.05, 
Figure 2).
All but one of the 12 treated patients had complete regres-
sion of ROP after treatment. This Group 2 preterm, with 
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led to a reduced occurrence of severe ROP among very low 
BW preterm infants.18 The guidelines issued by the American 
Academy of Pediatrics presently recommend maintaining 
PaO
2
 at 45–80 mmHg with oxygen saturation limits of 85% 
for preterm infants with GA . 32 weeks, and 85%–93% for 
newborn infants with GA , 32 weeks.19
There are other suggested risk factors for ROP, such as 
hyperoxia; hypoxia; use of indomethacin, surfactants, and 
erythropoietin; occurrence of sepsis or intraventricular hem-
orrhage; and postnatal low weight gain, but with inconclusive 
results.20 This study did not include these factors within its 
parameters.
Recently, multiple pregnancies have been studied as a 
risk factor for ROP.8,9,21,22 Incidence of multiples increased 
400% in the last 20 years, especially in triplets,7 possi-
bly because of a higher incidence of pregnancy in older 
women, as well as a larger number of assisted pregnancies 
or fertilizations.8,10,11,22
Improvements in perinatal and neonatal intensive care has 
reduced the mortality rate of extremely low-BW infants.23 
Multiple pregnancies usually present babies with low GA 
and BW, both considered the main risk factor to develop 
ROP.7 Incidences of ROP are increasing in many countries,2 
including Brazil, but this study could not find any reports on 
this issue in the Brazilian scientific literature.
With regard to threshold ROP, recent articles show incon-
clusive results comparing preterm babies born from single 
and multiple pregnancies. McKibbin et al related a higher 
incidence of threshold ROP among multiples born from 
assisted pregnancies.22 On the other hand, Blumenfeld et al 
found similar occurrence of stages 1, 2, and 3 ROP (prethre-
shold or threshold) when analyzing 149 premature infants 
from multiple gestations compared to 691 singletons.9 Watts 
and Adams related that in vitro fertilization could be a risk 
factor for threshold ROP after studying 179 preterm children 
born from different assisted conceptional methods, but the 
authors did not mention multiple pregnancies.11 The current 
study did not find statistical significance regarding the need 
for treatment between Groups 1 and 2, as in agreement with 
Blumenfeld et al,9 but the small number of threshold ROP 
patients in Group 1 may have influenced this result.
Twelve patients in the entire cohort were treated for 
threshold ROP in this study. Eleven of them were treated 
with transpupillary diode laser, and ten (90.9%) presented 
regression of threshold ROP. Only one child had an unfavor-
able outcome. This infant, belonging to Group 2, underwent 
diode laser therapy but progressed to stage 4B of ROP despite 
scleral buckling procedure in his right eye, and progressed to 
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Figure 1 Retinopathy of prematurity (ROP) in multiples vs singles.
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Figure 2 Threshold retinopathy of prematurity (ROP).
unfavorable outcome, underwent laser therapy but progressed 
to stage 4B of ROP despite scleral buckling procedure in his 
right eye, and progressed to stage 5 of ROP in his left eye, 
despite pars plicata vitrectomy.
Discussion
There were 35% of multiple-gestation patients among the 
prospectively studied cohort of patients. Both Laranjeiras 
and Amparo neonatal units are reference centers for assisted 
pregnancies, which may explain the higher incidence of 
multiples in this study when compared to other authors.17 
According to Barr et al, there are around 10% of prematurity 
among singletons. Among twins and triplets, 47% and 90%, 
respectively, born prematurely and with low BW.7
In Group 1, 30 patients (53.6%) achieved any stage of 
ROP and, in Group 2, 36 patients (35%) achieved any stage of 
ROP (Chi-square test P , 0.05). Threshold ROP occurred in 
three (5.3%) patients in Group 1, and in nine (8.7%), patients 
in Group 2 (Chi-square test P . 0.05). Both groups were simi-
lar regarding GA, BW, and duration of oxygen therapy. Days 
in oxygen therapy ranged from 0 to 188 days. Median among 
Group 1 was 15 days while median in Group 2 was 10 days 
(Kruskal–Wallis P . 0.05). This study did not find reference 
to all of these parameters simultaneously when groups were 
compared, which could explain the difference in the findings. 
Current knowledge about how to avoid fluctuation in the oxy-
gen levels delivered to the preterm during the period under 
oxygen therapy (by monitoring PaO
2
 by pulse oximetry) has 
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stage 5 of ROP in his left eye despite pars plicata  vitrectomy. 
Only one child was treated with cryotherapy with good 
outcomes. These results are similar to those described by 
other authors.6,9,14
Of the 159 patients considered in this study, 66 (41.5%) 
had any stage ROP. The results of this study support current 
literature.2,4,26 Although comparison with historic control 
groups allows patient selection, and thus ensure inclusion 
criteria are homogenous, it does not recognize that other 
factors, such as new drugs, advanced technologies, changes 
in NICU routines, or changes in population characteristics 
(like an increase of gemelarity), could affect the results.
McKibbin et al performed screening examination to eval-
uate ROP in 20% of children born after assisted conception.22 
Twenty-three percent of the subjects presented with some 
stage of ROP, with a high incidence of patients requiring 
treatment. McKibbin et al did not mention the proportion of 
twin births in the population studied.22
Friling et al found in 99 newborns from multiples gesta-
tion and BW of 1500 g or less, a higher risk of developing 
ROP in the second twin, but logistic regression analysis 
showed that the smaller BW of the second twin, and not the 
order of deliverance, was the most important factor to ROP.8
Blumenfeld et al compared 149 infants born from mul-
tiple pregnancies to 691 from single pregnancies, and found 
ROP in 69 (46%) of twins and 312 (45%) of singletons, 
with no statistical difference in the incidence of the disease 
between the groups.9
Tomazzoli et al studied ROP in 77 premature twins or 
triplets and compared them to 120 premature singletons; 
they found a higher frequency of ROP in low BW twins and 
triplets, with no statistic difference.26
Baar et al26 did not find ROP greater than stage 1 in 
the 51-strong party of triplets evaluated for 10 years, but 
Kaufman et al10  suggested that triplets had a greater risk 
of  ROP.
When this study noted the occurrence of any stage ROP in 
Group 1 (56 twins), 30 (53,6%) had the disease, and in Group 
2 (103 singletons), 36 (35%) had any stage ROP. Chi-square 
test showed that Group 1 had a higher frequency of any stage 
of ROP than Group 2, which was statistically significant. 
However, the study did not include logistic regression to 
analyze behavior of gemelarity as a risk factor for ROP under 
influence of the other studied risk factors.
These data support the higher frequency of any stage 
of ROP among multiples (Group 1) but not regarding 
threshold ROP. In this study, three patients (5.3%) from 
Group 1 (multiples) and nine patients (8.7%) in Group 2 
(singletons) reached threshold ROP needing diode laser 
treatment (Fisher’s exact test P . 0.05). Although babies 
born from multiple gestations appear to have the same GA, 
the siblings can have different intrauterine maturity levels 
by birth. In addition, they can achieve different clinical 
course during the postnatal period and this can affect the 
occurrences of ROP, and of severe ROP needing treatment 
among these patients.
As studies concerning gemelarity among very low BW 
preterm infants have the limitation of the small number of 
included patients, it is necessary to have more studies in this 
subject in order to determine if and how gemelarity plays a 
role in the occurrence of ROP.
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